-
People and CultureEnabling 130,000 employees to grow in an organization committed to continuous learning
Our Chief Learning Officer, Simon Brown, talks about our ongoing efforts to build new capabilities by investing in our own people.
People and Culture -
Access to HealthcareNovartis Access impact evaluation: progress update on our work with Boston University
Boston University developed a methodology to evaluate the impact of Novartis Access in Kenya. Peter C. Rockers tells us about the ongoing study.
Access to Healthcare -
From Our LabsHow a 19th-century technology is speeding up drug discovery
Pneumatic tube systems have existed for 150+ years and have transported everything from telegrams to aircraft parts. Now they’re being used in our labs.
From Our Labs -
People and CultureFlexibility at Novartis: Deepti Mittal
Mittal shares how flexible working helped her and her family get through a difficult time.
People and Culture -
People and CultureFlexibility at Novartis: Peter Canavan
Canavan describes how flexible working positively impacts his team.
People and Culture -
DiscoveryWomen in Science: Susanne Schaffert
Susanne Schaffert, President of Advanced Accelerator Applications, describes her career in science.
Discovery -
DiscoveryBringing real change to people
An interview with Thierry Diagana, Head of the Novartis Institute for Tropical Diseases.
Discovery -
Patient PerspectivesThe changing landscape of cancer treatment
Patient Perspectives -
Access to HealthcareImproving lives through community-based care
Bringing healthcare closer to where people live, work and shop can effectively tackle hypertension – the most deadly noncommunicable disease.
Access to Healthcare -
DiscoveryFrom patient to patient advocate: how a cancer diagnosis fueled a new career path
Elyse Spatz Caplan’s cancer diagnosis impacted her life in more ways than 1
Discovery -
DiscoveryAn up-close look at cryo-electron microscopy
Scientists are using the imaging technique to see complex molecular structures in stunning detail.
Discovery -
From Our LabsReimagining protein sequencing
Three years after discussing how to reuse an old scientific measuring device, Novartis scientists are now testing this idea as part of an innovative research project.
From Our Labs